Session

Hepatology: Disease mechanisms

THE ERADICATION OF HEPATITIS C VIRUS WITH DIRECT ANTIVIRAL AGENTS REPROGRAMS MITOCHONDRIAL METABOLISM IN PERIPHERAL BLOOD MONONUCLEAR CELLS
THE ERADICATION OF HEPATITIS C VIRUS WITH DIRECT ANTIVIRAL AGENTS REPROGRAMS MITOCHONDRIAL METABOLISM IN PERIPHERAL BLOOD MONONUCLEAR CELLS

REAL-WORLD ASSESSMENT OF THE EXCHANGEABLE COPPER (CUEXC) AND THE RATIO OF EXCHANGEABLE COPPER (REC) AS NON-INVASIVE TOOLS FOR WILSON'S DISEASE DIAGNOSIS AND FOLLOW-UP
REAL-WORLD ASSESSMENT OF THE EXCHANGEABLE COPPER (CUEXC) AND THE RATIO OF EXCHANGEABLE COPPER (REC) AS NON-INVASIVE TOOLS FOR WILSON'S DISEASE DIAGNOSIS AND FOLLOW-UP

NOVEL PREDICTORS FOR LIVER TRANSPLANTATION OR DEATH IN DRUG-INDUCED ACUTE LIVER FAILURE
NOVEL PREDICTORS FOR LIVER TRANSPLANTATION OR DEATH IN DRUG-INDUCED ACUTE LIVER FAILURE

EARLIER IDENTIFICATION OF STEROID RESPONDERS IN SEVERE ALCOHOLIC HEPATITIS
EARLIER IDENTIFICATION OF STEROID RESPONDERS IN SEVERE ALCOHOLIC HEPATITIS

ROLE OF PROGRAMMED DEATH-LIGAND 1 (PD-L1) POLYMORPHISMS AS RISK FACTORS FOR THE DEVELOPMENT OF CHRONIC HCV-RELATED COMPLICATIONS IN EGYPTIAN POPULATION
ROLE OF PROGRAMMED DEATH-LIGAND 1 (PD-L1) POLYMORPHISMS AS RISK FACTORS FOR THE DEVELOPMENT OF CHRONIC HCV-RELATED COMPLICATIONS IN EGYPTIAN POPULATION

LIVER DISEASE-ASSOCIATED ACE ACTIVITY IMPACTS ON FIBRINOLYSIS AND INFLAMMATION - A POTENTIAL LINK TO COVID-19
LIVER DISEASE-ASSOCIATED ACE ACTIVITY IMPACTS ON FIBRINOLYSIS AND INFLAMMATION - A POTENTIAL LINK TO COVID-19

THE ERADICATION OF HEPATITIS C VIRUS WITH DIRECT ANTIVIRAL AGENTS REPROGRAMS MITOCHONDRIAL METABOLISM IN PERIPHERAL BLOOD MONONUCLEAR CELLS
THE ERADICATION OF HEPATITIS C VIRUS WITH DIRECT ANTIVIRAL AGENTS REPROGRAMS MITOCHONDRIAL METABOLISM IN PERIPHERAL BLOOD MONONUCLEAR CELLS

Hepatology: Disease mechanisms

LIVER DISEASE-ASSOCIATED ACE ACTIVITY IMPACTS ON FIBRINOLYSIS AND INFLAMMATION - A POTENTIAL LINK TO COVID-19
LIVER DISEASE-ASSOCIATED ACE ACTIVITY IMPACTS ON FIBRINOLYSIS AND INFLAMMATION - A POTENTIAL LINK TO COVID-19

Hepatology: Disease mechanisms

REAL-WORLD ASSESSMENT OF THE EXCHANGEABLE COPPER (CUEXC) AND THE RATIO OF EXCHANGEABLE COPPER (REC) AS NON-INVASIVE TOOLS FOR WILSON´S DISEASE DIAGNOSIS AND FOLLOW-UP
REAL-WORLD ASSESSMENT OF THE EXCHANGEABLE COPPER (CUEXC) AND THE RATIO OF EXCHANGEABLE COPPER (REC) AS NON-INVASIVE TOOLS FOR WILSON´S DISEASE DIAGNOSIS AND FOLLOW-UP

Hepatology: Disease mechanisms

ROLE OF PROGRAMMED DEATH-LIGAND 1 (PD-L1) POLYMORPHISMS AS RISK FACTORS FOR THE DEVELOPMENT OF CHRONIC HCV-RELATED COMPLICATIONS IN EGYPTIAN POPULATION
ROLE OF PROGRAMMED DEATH-LIGAND 1 (PD-L1) POLYMORPHISMS AS RISK FACTORS FOR THE DEVELOPMENT OF CHRONIC HCV-RELATED COMPLICATIONS IN EGYPTIAN POPULATION

Hepatology: Disease mechanisms

NOVEL PREDICTORS FOR LIVER TRANSPLANTATION OR DEATH IN DRUG-INDUCED ACUTE LIVER FAILURE
NOVEL PREDICTORS FOR LIVER TRANSPLANTATION OR DEATH IN DRUG-INDUCED ACUTE LIVER FAILURE

Hepatology: Disease mechanisms

EARLIER IDENTIFICATION OF STEROID RESPONDERS IN SEVERE ALCOHOLIC HEPATITIS
EARLIER IDENTIFICATION OF STEROID RESPONDERS IN SEVERE ALCOHOLIC HEPATITIS

Hepatology: Disease mechanisms

LIVER DISEASE-ASSOCIATED ACE ACTIVITY IMPACTS ON FIBRINOLYSIS AND INFLAMMATION - A POTENTIAL LINK TO COVID-19
LIVER DISEASE-ASSOCIATED ACE ACTIVITY IMPACTS ON FIBRINOLYSIS AND INFLAMMATION - A POTENTIAL LINK TO COVID-19

Hepatology: Disease mechanisms  et al.

ROLE OF PROGRAMMED DEATH-LIGAND 1 (PD-L1) POLYMORPHISMS AS RISK FACTORS FOR THE DEVELOPMENT OF CHRONIC HCV-RELATED COMPLICATIONS IN EGYPTIAN POPULATION
ROLE OF PROGRAMMED DEATH-LIGAND 1 (PD-L1) POLYMORPHISMS AS RISK FACTORS FOR THE DEVELOPMENT OF CHRONIC HCV-RELATED COMPLICATIONS IN EGYPTIAN POPULATION

Hepatology: Disease mechanisms  et al.

EARLIER IDENTIFICATION OF STEROID RESPONDERS IN SEVERE ALCOHOLIC HEPATITIS
EARLIER IDENTIFICATION OF STEROID RESPONDERS IN SEVERE ALCOHOLIC HEPATITIS

Hepatology: Disease mechanisms  et al.

NOVEL PREDICTORS FOR LIVER TRANSPLANTATION OR DEATH IN DRUG-INDUCED ACUTE LIVER FAILURE
NOVEL PREDICTORS FOR LIVER TRANSPLANTATION OR DEATH IN DRUG-INDUCED ACUTE LIVER FAILURE

Hepatology: Disease mechanisms  et al.

REAL-WORLD ASSESSMENT OF THE EXCHANGEABLE COPPER (CUEXC) AND THE RATIO OF EXCHANGEABLE COPPER (REC) AS NON-INVASIVE TOOLS FOR WILSON´S DISEASE DIAGNOSIS AND FOLLOW-UP
REAL-WORLD ASSESSMENT OF THE EXCHANGEABLE COPPER (CUEXC) AND THE RATIO OF EXCHANGEABLE COPPER (REC) AS NON-INVASIVE TOOLS FOR WILSON´S DISEASE DIAGNOSIS AND FOLLOW-UP

Hepatology: Disease mechanisms  et al.

THE ERADICATION OF HEPATITIS C VIRUS WITH DIRECT ANTIVIRAL AGENTS REPROGRAMS MITOCHONDRIAL METABOLISM IN PERIPHERAL BLOOD MONONUCLEAR CELLS
THE ERADICATION OF HEPATITIS C VIRUS WITH DIRECT ANTIVIRAL AGENTS REPROGRAMS MITOCHONDRIAL METABOLISM IN PERIPHERAL BLOOD MONONUCLEAR CELLS

Hepatology: Disease mechanisms  et al.

Item 1 - 18 / 18
1